한글목차

세계 기침약 시장 규모는 꾸준히 증가하여 2025년에는 287억 5,000만 달러로 급증하고 2032년에는 443억 8,000만 달러로 더욱 성장할 것으로 예상됩니다. 이러한 성장에는 호흡기질환의 증가, 소비자 인식의 증가, 제약 솔루션의 발전이 기여하고 있으며, CAGR은 6.4%입니다.

기침약(진해제)은 기침의 충동을 최소화하기 위해 처방되는 의약품입니다. 이들 의약품은 뇌의 기침 반사에 영향을 미쳐 작용하며 호흡기 감염, 알레르겐, 환경오염물질로 인한 증상 완화에 도움을 줍니다. 이 시장에서는 환자의 편의성과 치료성 향상을 위해 새로운 약물의 조합, 전달 메커니즘 강화 등 기술 혁신의 물결이 일고 있습니다.

소비자들의 건강에 대한 인식이 높아지면서 일반의약품(OTC) 기침약에 대한 수요가 확대되고 있습니다. 공해, 계절성 감염, 알레르겐 등 다양한 호흡기질환의 확산이 시장 확대를 견인하고 있습니다. 소비자들은 지속적인 기침에 대한 효과적인 치료법을 적극적으로 찾고 있으며, 이는 기침약 제품 판매를 증가시키고 있습니다. 업체들은 효능을 개선하고 부작용을 줄인 제제 개발에 주력하고 있습니다. 시장은 여러 유효 성분을 통합하여 종합적인 완화를 도모하는 복합 요법으로 전환하고 있습니다. 액상 캡슐, 가글, 스프레이 등 보다 사용하기 쉬운 제형이 소비자들에게 인기를 끌고 있습니다.

세계의 기침약 시장에 대해 조사했으며, 시장 개요와 함께 종류별, 약품별, 형태별, 유통 채널별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 정의와 세분화
• 시장 역학
• 밸류체인 분석
• Porter's Five Forces 분석
• COVID-19의 영향 분석
• 우크라이나·러시아 분쟁의 영향
• 경제 개요
• PESTLE 분석

제3장 가격 분석, 2019-2023년

제4장 세계의 기침약 시장 전망, 2019-2032년

• 세계의 기침약 시장 전망, 유형별, 금액(10억 달러), 수량(개), 2019-2032년
• 세계의 기침약 시장 전망, 약제별, 금액(10억 달러), 수량(개), 2019-2032년
• 세계의 기침약 시장 전망, 형태별, 금액(10억 달러), 수량(개), 2019-2032년
• 세계의 기침약 시장 전망, 유통 채널별, 금액(10억 달러), 수량(개), 2019-2032년
• 세계의 기침약 시장 전망, 지역별, 금액(10억 달러), 수량(개), 2019-2032년

제5장 북미의 기침약 시장 전망, 2019-2032년

제6장 유럽의 기침약 시장 전망, 2019-2032년

제7장 아시아태평양의 기침약 시장 전망, 2019-2032년

제8장 라틴아메리카의 기침약 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 기침약 시장 전망, 2019-2032년

제10장 경쟁 구도

• 유형별 vs약제별 히트맵
• 기업 시장 점유율 분석, 2024년
• 경쟁 대시보드
• 기업 개요
  • Abbott Laboratories
  • Acella Pharmaceuticals, LLC
  • GlaxoSmithKline Plc
  • Johnson & Johnson services Inc.
  • Merck KGaA
  • Novartis International AG
  • Pfizer Inc.
  • Procter & Gamble

제11장 부록

영문목차

The global market for cough suppressants is on a steady rise, with projections indicating a surge in value to USD 28.75 billion by 2025 and further growth to USD 44.38 billion by 2032. This expansion is fueled by increasing respiratory ailments, heightened consumer awareness, and advancements in pharmaceutical solutions, driving a compound annual growth rate (CAGR) of 6.4%.

Market Dynamics

Cough suppressants, or antitussives, are pharmaceutical products formulated to minimize the urge to cough. These medications work by influencing the brain's cough reflex, helping alleviate symptoms caused by respiratory infections, allergens, and environmental pollutants. The market is witnessing a wave of innovations, including novel drug combinations and enhanced delivery mechanisms, aimed at improving patient convenience and treatment outcomes.

Growth Drivers

Increasing Health Consciousness & Respiratory Conditions

• A rise in consumer health awareness is leading to a greater demand for over-the-counter (OTC) cough treatments.
• The growing prevalence of respiratory illnesses due to pollution, seasonal infections, and allergens is pushing market expansion.
• Consumers are actively seeking effective remedies for persistent coughs, increasing sales of cough suppressant products.

Innovation & Expansion in Product Offerings

• Companies are prioritizing R&D to develop enhanced formulations with improved efficacy and reduced side effects.
• The market is shifting toward combination therapies that integrate multiple active ingredients for comprehensive relief.
• More user-friendly formats, including liquid capsules, lozenges, and sprays, are gaining popularity among consumers.

Business Opportunities

Development of Pediatric-Specific Products

• Expanding product lines to include child-friendly formulations with appealing flavors and easy-to-administer formats can address unmet demand.
• Parents are increasingly searching for safe and effective cough treatments for children, presenting an untapped growth area.

Demand for Natural & Herbal Cough Remedies

• The increasing preference for natural remedies is encouraging manufacturers to introduce cough suppressants with herbal ingredients such as honey, ginger, and botanical extracts.
• Brands that cater to the trend of holistic wellness and natural healthcare will have a competitive advantage in the market.

Market Challenges

Regulatory Constraints

• Stricter regulations on OTC medications pose challenges for market players in terms of compliance and approval.
• Continuous investment in research and development is necessary to ensure products meet evolving quality and safety standards.

Supply Chain Issues

• Rising consumer demand, particularly during peak seasons, puts pressure on supply chains.
• Raw material shortages, logistical barriers, and workforce disruptions create hurdles in maintaining product availability.
• Companies must adopt resilient supply chain strategies to maintain consistent distribution.

Regional Insights

Europe: Market Leader

• The region benefits from strong healthcare systems, a high incidence of respiratory conditions, and an aging population with greater susceptibility to cough-related ailments.
• Strict pharmaceutical regulations ensure high product quality, reinforcing consumer trust and market stability.
• A growing preference for self-medication and increased awareness of OTC cough remedies contribute to market expansion.

South Asia & Pacific: Fastest-Growing Market

• Rising awareness about health and increasing respiratory issues drive demand for cough suppressants in this region.
• Changing environmental conditions and lifestyle factors contribute to a rise in respiratory infections, fueling market growth.
• A developing healthcare Analysis and a shift toward OTC medication usage make this region an emerging hotspot for market expansion.

Leading Market Players

The cough suppressant market is highly competitive, with key players focusing on innovation and strategic growth. Notable companies in the sector include:

• Abbott Laboratories
• Acella Pharmaceuticals, LLC
• GlaxoSmithKline Plc
• Johnson & Johnson Services Inc.
• Merck KGaA
• Novartis International AG
• Pfizer Inc.
• Procter & Gamble

Noteworthy Developments

New Product Introductions

• 2021: Sun Pharmaceutical Industries introduced Chericof 12 in India, featuring an advanced formulation designed to enhance patient recovery from cough symptoms.
• Market Impact: This innovation highlights the pharmaceutical sector's commitment to addressing evolving healthcare needs with effective cough suppressant solutions.

Strategic Acquisitions

• 2023: GSK Plc acquired Bellus Health Inc., strengthening its portfolio of treatments for cough and related respiratory conditions.
• Market Impact: This acquisition reinforces GSK's position in the market, enhancing its ability to provide diverse and effective cough suppressant solutions while expanding its global reach.

Market Segmentation

The cough suppressant market is categorized based on type, active ingredients, form, sales channels, and geography.

By Type:

• Acute Cough
• Chronic Cough

By Active Ingredients:

• Dextromethorphan
• Codeine
• Butramirate
• Benzonatate
• Others

By Form:

• Tablets/Capsules
• Liquid Syrups
• Sprays

By Sales Channels:

• Hospitals
• Retail Pharmacies
• Drug Stores
• E-commerce Platforms

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Cough Suppressant Market Snapshot
• 1.2. Future Projections
• 1.3. Key Market Trends
• 1.4. Regional Snapshot, by Value and Volume, 2024
• 1.5. Analyst Recommendations

2. Market Overview

• 2.1. Market Definitions and Segmentations
• 2.2. Market Dynamics
  • 2.2.1. Drivers
  • 2.2.2. Restraints
  • 2.2.3. Market Opportunities
• 2.3. Value Chain Analysis
• 2.4. Porter's Five Forces Analysis
• 2.5. COVID-19 Impact Analysis
  • 2.5.1. Supply
  • 2.5.2. Demand
• 2.6. Impact of Ukraine-Russia Conflict
• 2.7. Economic Overview
  • 2.7.1. World Economic Projections
• 2.8. PESTLE Analysis

3. Price Analysis, 2019 - 2023

• 3.1. Global Average Price Analysis by Type, 2019 - 2023
• 3.2. Prominent Factor Affecting Cough Suppressant Prices
• 3.3. Global Average Price Analysis by Region

4. Global Cough Suppressant Market Outlook, 2019 - 2032

• 4.1. Global Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.1.1. Key Highlights
    • 4.1.1.1. Acute Cough
    • 4.1.1.2. Chronic Cough
• 4.2. Global Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.2.1. Key Highlights
    • 4.2.1.1. Dextromethorphan
    • 4.2.1.2. Codeine
    • 4.2.1.3. Butramirate
    • 4.2.1.4. Bennzonatate
    • 4.2.1.5. Others
• 4.3. Global Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.3.1. Key Highlights
    • 4.3.1.1. Solid
    • 4.3.1.2. Liquid
    • 4.3.1.3. Spray
• 4.4. Global Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.4.1. Key Highlights
    • 4.4.1.1. Hospitals
    • 4.4.1.2. Retail Pharmacies
    • 4.4.1.3. Drug Stores
    • 4.4.1.4. Online Pharmacies
• 4.5. Global Cough Suppressant Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 4.5.1. Key Highlights
    • 4.5.1.1. North America
    • 4.5.1.2. Europe
    • 4.5.1.3. Asia Pacific
    • 4.5.1.4. Latin America
    • 4.5.1.5. Middle East & Africa

5. North America Cough Suppressant Market Outlook, 2019 - 2032

• 5.1. North America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.1.1. Key Highlights
    • 5.1.1.1. Acute Cough
    • 5.1.1.2. Chronic Cough
• 5.2. North America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.2.1. Key Highlights
    • 5.2.1.1. Dextromethorphan
    • 5.2.1.2. Codeine
    • 5.2.1.3. Butramirate
    • 5.2.1.4. Bennzonatate
    • 5.2.1.5. Others
• 5.3. North America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.3.1. Key Highlights
    • 5.3.1.1. Solid
    • 5.3.1.2. Liquid
    • 5.3.1.3. Spray
• 5.4. North America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.4.1. Key Highlights
    • 5.4.1.1. Hospitals
    • 5.4.1.2. Retail Pharmacies
    • 5.4.1.3. Drug Stores
    • 5.4.1.4. Online Pharmacies
  • 5.4.2. Attractiveness Analysis
• 5.5. North America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 5.5.1. Key Highlights
    • 5.5.1.1. U.S. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.2. U.S. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.3. U.S. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.4. U.S. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.5. Canada Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.6. Canada Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.7. Canada Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.5.1.8. Canada Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

6. Europe Cough Suppressant Market Outlook, 2019 - 2032

• 6.1. Europe Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.1.1. Key Highlights
    • 6.1.1.1. Acute Cough
    • 6.1.1.2. Chronic Cough
• 6.2. Europe Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.2.1. Key Highlights
    • 6.2.1.1. Dextromethorphan
    • 6.2.1.2. Codeine
    • 6.2.1.3. Butramirate
    • 6.2.1.4. Bennzonatate
    • 6.2.1.5. Others
• 6.3. Europe Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.3.1. Key Highlights
    • 6.3.1.1. Solid
    • 6.3.1.2. Liquid
    • 6.3.1.3. Spray
• 6.4. Europe Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.4.1. Key Highlights
    • 6.4.1.1. Hospitals
    • 6.4.1.2. Retail Pharmacies
    • 6.4.1.3. Drug Stores
    • 6.4.1.4. Online Pharmacies
  • 6.4.2. Attractiveness Analysis
• 6.5. Europe Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 6.5.1. Key Highlights
    • 6.5.1.1. Germany Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.2. Germany Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.3. Germany Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.4. Germany Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.5. U.K. Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.6. U.K. Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.7. U.K. Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.8. U.K. Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.9. France Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.10. France Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.11. France Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.12. France Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.13. Italy Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.14. Italy Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.15. Italy Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.16. Italy Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.17. Turkey Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.18. Turkey Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.19. Turkey Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.20. Turkey Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.21. Russia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.22. Russia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.23. Russia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.24. Russia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.25. Rest of Europe Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.26. Rest of Europe Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.27. Rest of Europe Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.5.1.28. Rest of Europe Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

7. Asia Pacific Cough Suppressant Market Outlook, 2019 - 2032

• 7.1. Asia Pacific Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.1.1. Key Highlights
    • 7.1.1.1. Acute Cough
    • 7.1.1.2. Chronic Cough
• 7.2. Asia Pacific Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.2.1. Key Highlights
    • 7.2.1.1. Dextromethorphan
    • 7.2.1.2. Codeine
    • 7.2.1.3. Butramirate
    • 7.2.1.4. Bennzonatate
    • 7.2.1.5. Others
• 7.3. Asia Pacific Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.3.1. Key Highlights
    • 7.3.1.1. Solid
    • 7.3.1.2. Liquid
    • 7.3.1.3. Spray
• 7.4. Asia Pacific Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.4.1. Key Highlights
    • 7.4.1.1. Hospitals
    • 7.4.1.2. Retail Pharmacies
    • 7.4.1.3. Drug Stores
    • 7.4.1.4. Online Pharmacies
  • 7.4.2. Attractiveness Analysis
• 7.5. Asia Pacific Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 7.5.1. Key Highlights
    • 7.5.1.1. China Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.2. China Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.3. China Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.4. China Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.5. Japan Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.6. Japan Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.7. Japan Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.8. Japan Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.9. South Korea Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.10. South Korea Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.11. South Korea Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.12. South Korea Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.13. India Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.14. India Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.15. India Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.16. India Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.17. Southeast Asia Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.18. Southeast Asia Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.19. Southeast Asia Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.20. Southeast Asia Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.21. Rest of Asia Pacific Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.22. Rest of Asia Pacific Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.23. Rest of Asia Pacific Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.5.1.24. Rest of Asia Pacific Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

8. Latin America Cough Suppressant Market Outlook, 2019 - 2032

• 8.1. Latin America Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.1.1. Key Highlights
    • 8.1.1.1. Acute Cough
    • 8.1.1.2. Chronic Cough
• 8.2. Latin America Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.2.1. Key Highlights
    • 8.2.1.1. Dextromethorphan
    • 8.2.1.2. Codeine
    • 8.2.1.3. Butramirate
    • 8.2.1.4. Bennzonatate
    • 8.2.1.5. Others
• 8.3. Latin America Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.3.1. Key Highlights
    • 8.3.1.1. Solid
    • 8.3.1.2. Liquid
    • 8.3.1.3. Spray
• 8.4. Latin America Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.4.1. Key Highlights
    • 8.4.1.1. Hospitals
    • 8.4.1.2. Retail Pharmacies
    • 8.4.1.3. Drug Stores
    • 8.4.1.4. Online Pharmacies
  • 8.4.2. Attractiveness Analysis
• 8.5. Latin America Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 8.5.1. Key Highlights
    • 8.5.1.1. Brazil Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.2. Brazil Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.3. Brazil Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.4. Brazil Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.5. Mexico Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.6. Mexico Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.7. Mexico Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.8. Mexico Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.9. Argentina Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.10. Argentina Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.11. Argentina Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.12. Argentina Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.13. Rest of Latin America Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.14. Rest of Latin America Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.15. Rest of Latin America Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.5.1.16. Rest of Latin America Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

9. Middle East & Africa Cough Suppressant Market Outlook, 2019 - 2032

• 9.1. Middle East & Africa Cough Suppressant Market Outlook, by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.1.1. Key Highlights
    • 9.1.1.1. Acute Cough
    • 9.1.1.2. Chronic Cough
• 9.2. Middle East & Africa Cough Suppressant Market Outlook, by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.2.1. Key Highlights
    • 9.2.1.1. Dextromethorphan
    • 9.2.1.2. Codeine
    • 9.2.1.3. Butramirate
    • 9.2.1.4. Bennzonatate
    • 9.2.1.5. Others
• 9.3. Middle East & Africa Cough Suppressant Market Outlook, by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.3.1. Key Highlights
    • 9.3.1.1. Solid
    • 9.3.1.2. Liquid
    • 9.3.1.3. Spray
• 9.4. Middle East & Africa Cough Suppressant Market Outlook, by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.4.1. Key Highlights
    • 9.4.1.1. Hospitals
    • 9.4.1.2. Retail Pharmacies
    • 9.4.1.3. Drug Stores
    • 9.4.1.4. Online Pharmacies
  • 9.4.2. Attractiveness Analysis
• 9.5. Middle East & Africa Cough Suppressant Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
  • 9.5.1. Key Highlights
    • 9.5.1.1. GCC Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.2. GCC Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.3. GCC Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.4. GCC Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.5. South Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.6. South Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.7. South Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.8. South Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.9. Egypt Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.10. Egypt Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.11. Egypt Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.12. Egypt Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.13. Nigeria Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.14. Nigeria Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.15. Nigeria Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.16. Nigeria Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.17. Rest of Middle East & Africa Cough Suppressant Market by Type, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.18. Rest of Middle East & Africa Cough Suppressant Market by Drugs, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.19. Rest of Middle East & Africa Cough Suppressant Market by Form, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.5.1.20. Rest of Middle East & Africa Cough Suppressant Market by Distribution Channel, Value (US$ Bn) and Volume (Units), 2019 - 2032

10. Competitive Landscape

• 10.1. By Type vs by Drugs Heatmap
• 10.2. Company Market Share Analysis, 2024
• 10.3. Competitive Dashboard
• 10.4. Company Profiles
  • 10.4.1. Abbott Laboratories
    • 10.4.1.1. Company Overview
    • 10.4.1.2. Product Portfolio
    • 10.4.1.3. Financial Overview
    • 10.4.1.4. Business Strategies and Development
  • 10.4.2. Acella Pharmaceuticals, LLC
    • 10.4.2.1. Company Overview
    • 10.4.2.2. Product Portfolio
    • 10.4.2.3. Financial Overview
    • 10.4.2.4. Business Strategies and Development
  • 10.4.3. GlaxoSmithKline Plc
    • 10.4.3.1. Company Overview
    • 10.4.3.2. Product Portfolio
    • 10.4.3.3. Financial Overview
    • 10.4.3.4. Business Strategies and Development
  • 10.4.4. Johnson & Johnson services Inc.
    • 10.4.4.1. Company Overview
    • 10.4.4.2. Product Portfolio
    • 10.4.4.3. Financial Overview
    • 10.4.4.4. Business Strategies and Development
  • 10.4.5. Merck KGaA
    • 10.4.5.1. Company Overview
    • 10.4.5.2. Product Portfolio
    • 10.4.5.3. Financial Overview
    • 10.4.5.4. Business Strategies and Development
  • 10.4.6. Novartis International AG
    • 10.4.6.1. Company Overview
    • 10.4.6.2. Product Portfolio
    • 10.4.6.3. Financial Overview
    • 10.4.6.4. Business Strategies and Development
  • 10.4.7. Pfizer Inc.
    • 10.4.7.1. Company Overview
    • 10.4.7.2. Product Portfolio
    • 10.4.7.3. Financial Overview
    • 10.4.7.4. Business Strategies and Development
  • 10.4.8. Procter & Gamble
    • 10.4.8.1. Company Overview
    • 10.4.8.2. Product Portfolio
    • 10.4.8.3. Financial Overview
    • 10.4.8.4. Business Strategies and Development

11. Appendix

• 11.1. Research Methodology
• 11.2. Report Assumptions
• 11.3. Acronyms and Abbreviations